These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 37396707)

  • 1. Impacts of SARS-CoV-2 on diabetes mellitus: A pre and post pandemic evaluation.
    Nabi AHMN; Ebihara A; Shekhar HU
    World J Virol; 2023 Jun; 12(3):151-171. PubMed ID: 37396707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced endocytosis elevated virulence and severity of SARS-CoV-2 due to hyperglycemia in type 2 diabetic patients.
    Subbaram K; Ali PSS; Ali S
    Gene Rep; 2022 Mar; 26():101495. PubMed ID: 35043090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature.
    Ukwenya VO; Adelakun SA; Fuwape TA; Adeagbo AS
    Curr Diabetes Rev; 2022; 18(3):e060821195355. PubMed ID: 34365925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review.
    Das S; K R A; Birangal SR; Nikam AN; Pandey A; Mutalik S; Joseph A
    Life Sci; 2020 Oct; 258():118202. PubMed ID: 32758625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus and COVID-19: Understanding the association in light of current evidence.
    Sen S; Chakraborty R; Kalita P; Pathak MP
    World J Clin Cases; 2021 Oct; 9(28):8327-8339. PubMed ID: 34754842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).
    Noor R
    Arch Microbiol; 2021 Jul; 203(5):1943-1951. PubMed ID: 33682075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of COVID-19 pathogenesis in diabetes.
    Aluganti Narasimhulu C; Singla DK
    Am J Physiol Heart Circ Physiol; 2022 Sep; 323(3):H403-H420. PubMed ID: 35776683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress Hyperglycemia, Diabetes Mellitus and COVID-19 Infection: Risk Factors, Clinical Outcomes and Post-Discharge Implications.
    Gerganova A; Assyov Y; Kamenov Z
    Front Clin Diabetes Healthc; 2022; 3():826006. PubMed ID: 36992767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Drug Strategies to Target Coronaviruses.
    Sarkar K; Sil PC
    Adv Exp Med Biol; 2021; 1352():111-124. PubMed ID: 35132597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between SARS-CoV-2 Infection and Type II Diabetes.
    Azhar A; Khan WH; Al-Hosaini K; Zia Q; Kamal MA
    Comb Chem High Throughput Screen; 2022; 25(14):2429-2442. PubMed ID: 35293290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.
    Sanguedolce F; Zanelli M; Froio E; Bisagni A; Zizzo M; Ascani S; Stallone G; Netti S; Ranieri E; Falagario U; Carrieri G; Cormio L
    Crit Rev Clin Lab Sci; 2021 Dec; 58(8):563-575. PubMed ID: 34236278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Infections, Impaired Tissue, and Metabolic Health: Pathophysiology and Potential Therapeutics.
    Singh SP; Bhatnagar A; Singh SK; Patra SK; Kanwar N; Kanwal A; Amar S; Manna R
    Mini Rev Med Chem; 2022; 22(16):2102-2123. PubMed ID: 35105287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization.
    Johnson BS; Laloraya M
    Cytokine Growth Factor Rev; 2020 Aug; 54():32-42. PubMed ID: 32747157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus infection in patients with diabetes.
    Torres-Tamayo M; Caracas-Portillo NA; Peña-Aparicio B; Juárez-Rojas JG; Medina-Urrutia AX; Martínez-Alvarado MDR
    Arch Cardiol Mex; 2020; 90(Supl):67-76. PubMed ID: 32523141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection.
    Mezoh G; Crowther NJ
    Adv Exp Med Biol; 2021; 1321():33-43. PubMed ID: 33656711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus.
    Al-Kuraishy HM; Al-Gareeb AI; Alblihed M; Guerreiro SG; Cruz-Martins N; Batiha GE
    Front Cardiovasc Med; 2021; 8():644095. PubMed ID: 34124187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.